539730 FREDUN

Fredun Pharmaceuticals Share Price Fredun Pharmaceuticals

₹766.2
-8.35 (-1.08%)
20 April, 2024 12:01 BSE: 539730 NSE: FREDUNISIN: INE194R01017

Start SIP in Fredun Pharmaceuticals

Start SIP

Fredun Pharmaceuticals Performance

Day Range

  • Low 0
  • High 0
₹ 766

52 Week Range

  • Low 0
  • High 0
₹ 766
  • Open Price0
  • Previous Close0
  • Volume

Fredun Pharmaceuticals Share Price

  • Over 1 Month +6.52%
  • Over 3 Month -8.66%
  • Over 6 Month -8.31%
  • Over 1 Year -14%

Fredun Pharmaceuticals Key Statistics

Fredun Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 87816180
Operating Expenses Qtr Cr 76725468
Operating Profit Qtr Cr 109712
Depreciation Qtr Cr 1111
Interest Qtr Cr 4334
Tax Qtr Cr 2224
Net Profit Qtr Cr 4424
IndicatorMar 2023
Total Revenue Annual Cr 276
Operating Expenses Annual Cr 247
Operating Profit Annual in Cr 28
Depreciation Cr 3
Interest Annual Cr 9
Tax Annual Cr 7
Net Profit Annual Cr 11
IndicatorMar 2023
Cash from Operating Activity Annual Cr -14
Cash from Investing Activity Annual Cr -9
Cash from Financing Annual Activity Cr 25
Net Cash Flow Annual Cr 1
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 96
Fixed Assets Annual Cr 39
Total Non Current Assets Annual Cr 41
Total Current Assets Annual Cr 216
Total Assets Annual Cr 257
IndicatorMar 2023
Book Value Per Share Annual Rs 213
ROE Annual % 11
ROCE Annual % 18
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
₹766.2
-8.35 (-1.08%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹786.96
  • 50 Day
  • ₹805.28
  • 100 Day
  • ₹829.65
  • 200 Day
  • ₹861.64
  • 20 Day
  • ₹775.83
  • 50 Day
  • ₹815.04
  • 100 Day
  • ₹838.19
  • 200 Day
  • ₹873.75

Fredun Pharmaceuticals Resistance and Support

PIVOT
₹768.92
Resistance
First Resistance 781.73
Second Resistance 800.82
Third Resistance 813.63
RSI 44.84
MFI 46.60
MACD Single Line -5.37
MACD -5.43
Support
First Resistance 749.83
Second Resistance 737.02
Third Resistance 717.93

Fredun Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 8,975 782,889 87.23
Week 5,029 415,094 82.54
1 Month 8,688 660,496 76.02
6 Month 7,633 592,182 77.58

Fredun Pharmaceuticals Result Highlights

Fredun Pharmaceuticals Synopsis

BSE-Medical-Diversified

Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 274.68 Cr. and Equity Capital is Rs. 4.53 Cr. for the Year ended 31/03/2023. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.
Market Cap 356
Sales 309
Shares in Float 0.24
No of funds 1
Yield 0.09
Book Value 3.59
U/D Vol ratio 0.9
LTDebt / Equity 51
Alpha -0.15
Beta 1.25

Fredun Pharmaceuticals

Owner NameApr-24Mar-24Dec-23Sep-23
Promoters 49.13%49.17%49.16%49.31%
Financial Institutions/ Banks 1.6%1.6%1.6%1.6%
Individual Investors 43.7%44.02%43.67%43.48%
Others 5.57%5.21%5.57%5.61%

Fredun Pharmaceuticals Management

Name Designation
Dr.(Mrs.) Daulat N Medhora Chairman & Jt. M. D
Mr. Fredun Medhora Managing Director & CFO
Mr. Nariman Medhora Non Executive Director
Dr. Aspi Raimalwala Ind. Non-Executive Director
Dr. Rohinton Kanga Ind. Non-Executive Director

Fredun Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Fredun Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2023-12-16 Others Rs.0.00 alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method.
2023-11-08 Quarterly Results
2023-07-19 Quarterly Results
2023-05-24 Audited Results & Final Dividend
Date Purpose Remarks
2023-09-22 FINAL Rs.0.70 per share(7%)Final Dividend

Fredun Pharmaceuticals MF Shareholding

Name Amount(cr)

Fredun Pharmaceuticals FAQs

What is Share Price of Fredun Pharmaceuticals ?

Fredun Pharmaceuticals share price is ₹766 As on 20 April, 2024 | 11:47

What is the Market Cap of Fredun Pharmaceuticals ?

The Market Cap of Fredun Pharmaceuticals is ₹357.3 Cr As on 20 April, 2024 | 11:47

What is the P/E ratio of Fredun Pharmaceuticals ?

The P/E ratio of Fredun Pharmaceuticals is 24.7 As on 20 April, 2024 | 11:47

What is the PB ratio of Fredun Pharmaceuticals ?

The PB ratio of Fredun Pharmaceuticals is 3.7 As on 20 April, 2024 | 11:47

Q2FY23